Plain-English translation of NCT06482086 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new approach to treating locally advanced thyroid cancer. Instead of giving all patients the same medication, doctors will grow a sample of your tumor in the lab and test different drugs against it to see which ones work best for your specific cancer. You would then take the medication that your tumor is most sensitive to.
Locally advanced thyroid cancer is difficult to treat because the tumor has grown into nearby structures like the windpipe, food pipe, or major blood vessels. Surgery to remove these cancers can be very complex and risky. This trial is testing whether personalized drug selection can shrink tumors enough to make surgery safer or potentially avoid it altogether.
You likely qualify if…
You likely don't qualify if…
You would have a sample of your tumor collected, which doctors will then grow in the lab and test against different targeted drugs to identify the best option for you. Once the most effective medication is identified based on these tests, you would take that medication regularly as directed. The research team will monitor your tumor size before and after treatment, assess whether surgery becomes safer, and track your health outcomes and any side effects you experience.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
China